Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists

Overview of attention for article published in Cardiovascular Diabetology, October 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users
facebook: 1 Facebook page

video: 1 YouTube creator

Citations

dimensions_citation: 93 Dimensions

Readers on

mendeley: 217 Mendeley

Summary X Facebook YouTube Dimensions citations

So far, Dimensions has found 93 publications that cite this research output.

93

The most recent citing publications are shown below. View all 93 publications that cite this research output on Dimensions.

The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function

Article in Scientific Reports (February 2024)

Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification

Article in Diabetes & Metabolism Journal (January 2024)

The change in Fibrosis‐4 index in Japanese patients with type 2 diabetes treated by a fixed‐ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study

Article in Hepatology Research (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.